"In Detroit, Michigan, Ascension St. John Hospital is a full-service hospital with 24/7 emergency care and a Level I Trauma Center. We deliver advanced surgical care for serious and life-threatening injuries and illnesses. Our care teams listen to quickly understand your health needs and deliver care that's right for you. Ascension St. John is a destination for specialty care - including heart, cancer, stroke care, orthopedics and women’s health. Our OB-GYN maternity care teams at our Birthing Center deliver a personalized birthing experience and advanced neonatal care for sick babies. We offer a wide range of procedures using robotic-assisted technology, imaging and lab tests, a dedicated inpatient rehabilitation center, all on one campus."

During the past decade, Ascension Saint John Hospital conducted 250 clinical trials. In the 10-year time frame, 250 clinical trials started and 240 clinical trials were completed, i.e. on average, 96% percent of trials that started reached the finish line to date. In the past 5 years, 105 clinical trials started and 124 clinical trials were completed. i.e. 118.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Saint John Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 202 trials, followed by "Children's Oncology Group" with 77 trials sponsored, "SWOG Cancer Research Network" with 43 trials sponsored, "Alliance for Clinical Trials in Oncology" with 42 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 42 trials sponsored. Other sponsors include 148 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Saint John Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 219 trials as a collaborator, "NRG Oncology" with 45 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 7 trials as a collaborator. Other collaborators include 109 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Saint John Hospital" are "Recurrent Breast Carcinoma" (13 trials), "Coronary Artery Disease" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Stage IV Breast Cancer AJCC v6 and v7" (11 trials) and "Stage IV Lung Cancer AJCC v8" (11 trials). Many other conditions were trialed in "Ascension Saint John Hospital" in a lesser frequency.

Most popular intervention types in "Ascension Saint John Hospital" are "Drug" (366 trials), "Other" (280 trials), "Biological" (169 trials), "Procedure" (103 trials) and "Radiation" (77 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (155 trials), "Quality-of-Life Assessment" (90 trials), "Questionnaire Administration" (57 trials), "Carboplatin" (45 trials) and "Cisplatin" (45 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Saint John Hospital" are 459 trials for "All" genders, 66 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Ascension Saint John Hospital". undefined are not yet recruiting, 98 are recruiting, 179 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 213 completed trials in Ascension Saint John Hospital, 7 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Saint John Hospital, 19 "Phase 1" clinical trials were conducted, 212 "Phase 2" clinical trials and 225 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 52 trials that are defined as “Not Applicable".